421 related articles for article (PubMed ID: 25807494)
1. Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells.
Mengistu M; Ray K; Lewis GK; DeVico AL
PLoS Pathog; 2015 Mar; 11(3):e1004772. PubMed ID: 25807494
[TBL] [Abstract][Full Text] [Related]
2. Antigenic properties of the HIV envelope on virions in solution.
Ray K; Mengistu M; Yu L; Lewis GK; Lakowicz JR; DeVico AL
J Virol; 2014 Feb; 88(3):1795-808. PubMed ID: 24284318
[TBL] [Abstract][Full Text] [Related]
3. Patterns of conserved gp120 epitope presentation on attached HIV-1 virions.
Mengistu M; Tang AH; Foulke JS; Blanpied TA; Gonzalez MW; Spouge JL; Gallo RC; Lewis GK; DeVico AL
Proc Natl Acad Sci U S A; 2017 Nov; 114(46):E9893-E9902. PubMed ID: 29087304
[TBL] [Abstract][Full Text] [Related]
4. Concurrent Exposure of Neutralizing and Non-neutralizing Epitopes on a Single HIV-1 Envelope Structure.
Ray K; Mengistu M; Orlandi C; Pazgier M; Lewis GK; DeVico AL
Front Immunol; 2019; 10():1512. PubMed ID: 31338095
[TBL] [Abstract][Full Text] [Related]
5. Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes.
Martin L; Stricher F; Missé D; Sironi F; Pugnière M; Barthe P; Prado-Gotor R; Freulon I; Magne X; Roumestand C; Ménez A; Lusso P; Veas F; Vita C
Nat Biotechnol; 2003 Jan; 21(1):71-6. PubMed ID: 12483221
[TBL] [Abstract][Full Text] [Related]
6. Incompatible Natures of the HIV-1 Envelope in Resistance to the CCR5 Antagonist Cenicriviroc and to Neutralizing Antibodies.
Kuwata T; Enomoto I; Baba M; Matsushita S
Antimicrob Agents Chemother; 2016 Jan; 60(1):437-50. PubMed ID: 26525792
[TBL] [Abstract][Full Text] [Related]
7. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
[TBL] [Abstract][Full Text] [Related]
8. Conserved Role of an N-Linked Glycan on the Surface Antigen of Human Immunodeficiency Virus Type 1 Modulating Virus Sensitivity to Broadly Neutralizing Antibodies against the Receptor and Coreceptor Binding Sites.
Townsley S; Li Y; Kozyrev Y; Cleveland B; Hu SL
J Virol; 2016 Jan; 90(2):829-41. PubMed ID: 26512079
[TBL] [Abstract][Full Text] [Related]
9. The antigenic structure of the HIV gp120 envelope glycoprotein.
Wyatt R; Kwong PD; Desjardins E; Sweet RW; Robinson J; Hendrickson WA; Sodroski JG
Nature; 1998 Jun; 393(6686):705-11. PubMed ID: 9641684
[TBL] [Abstract][Full Text] [Related]
10. [Role of the HIV-1 gp120 V1/V2 domains in the induction of neutralizing antibodies].
Granados-González V; Piedrahita LD; Martínez M; Genin C; Riffard S; Urcuqui-Inchima S
Enferm Infecc Microbiol Clin; 2009 Nov; 27(9):523-30. PubMed ID: 19409660
[TBL] [Abstract][Full Text] [Related]
11. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
12. GP120: target for neutralizing HIV-1 antibodies.
Pantophlet R; Burton DR
Annu Rev Immunol; 2006; 24():739-69. PubMed ID: 16551265
[TBL] [Abstract][Full Text] [Related]
13. Induction of Fc-Mediated Effector Functions Against a Stabilized Inner Domain of HIV-1 gp120 Designed to Selectively Harbor the A32 Epitope Region.
Visciano ML; Gohain N; Sherburn R; Orlandi C; Flinko R; Dashti A; Lewis GK; Tolbert WD; Pazgier M
Front Immunol; 2019; 10():677. PubMed ID: 31001276
[TBL] [Abstract][Full Text] [Related]
14. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
[TBL] [Abstract][Full Text] [Related]
15. Antibody neutralization and escape by HIV-1.
Wei X; Decker JM; Wang S; Hui H; Kappes JC; Wu X; Salazar-Gonzalez JF; Salazar MG; Kilby JM; Saag MS; Komarova NL; Nowak MA; Hahn BH; Kwong PD; Shaw GM
Nature; 2003 Mar; 422(6929):307-12. PubMed ID: 12646921
[TBL] [Abstract][Full Text] [Related]
16. The C108g epitope in the V2 domain of gp120 functions as a potent neutralization target when introduced into envelope proteins derived from human immunodeficiency virus type 1 primary isolates.
Pinter A; Honnen WJ; D'Agostino P; Gorny MK; Zolla-Pazner S; Kayman SC
J Virol; 2005 Jun; 79(11):6909-17. PubMed ID: 15890930
[TBL] [Abstract][Full Text] [Related]
17. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes.
Moulard M; Phogat SK; Shu Y; Labrijn AF; Xiao X; Binley JM; Zhang MY; Sidorov IA; Broder CC; Robinson J; Parren PW; Burton DR; Dimitrov DS
Proc Natl Acad Sci U S A; 2002 May; 99(10):6913-8. PubMed ID: 11997472
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
[TBL] [Abstract][Full Text] [Related]
19. V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.
Laakso MM; Lee FH; Haggarty B; Agrawal C; Nolan KM; Biscone M; Romano J; Jordan AP; Leslie GJ; Meissner EG; Su L; Hoxie JA; Doms RW
PLoS Pathog; 2007 Aug; 3(8):e117. PubMed ID: 17722977
[TBL] [Abstract][Full Text] [Related]
20. Structural Basis for Epitopes in the gp120 Cluster A Region that Invokes Potent Effector Cell Activity.
Tolbert WD; Sherburn RT; Van V; Pazgier M
Viruses; 2019 Jan; 11(1):. PubMed ID: 30654465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
